Selective estrogen receptor modulators in the prevention of breast cancer in premenopausal women: a review

The detection of premenopausal women at high risk of breast cancer is key to chemoprevention. Therapy with selective estrogen receptor modulators (SERMs) induces a significant antiproliferative effect in estrogen receptor (ER) positive breast cancer. This review was designed according the guidelines...

Full description

Saved in:
Bibliographic Details
Published in:Translational cancer research 2020-07, Vol.9 (7), p.4444-4456
Main Authors: Oceguera-Basurto, Paola, Topete, Antonio, Oceguera-Villanueva, Antonio, Rivas-Carrillo, Jorge, Paz-Davalos, Marco, Quintero-Ramos, Antonio, Del Toro-Arreola, Alicia, Daneri-Navarro, Adrián
Format: Article
Language:English
Subjects:
Review
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The detection of premenopausal women at high risk of breast cancer is key to chemoprevention. Therapy with selective estrogen receptor modulators (SERMs) induces a significant antiproliferative effect in estrogen receptor (ER) positive breast cancer. This review was designed according the guidelines of the 2009 PRISMA statement. Searching different databases, including PubMed, MedlinePlus, PLoS One, Cochrane Breast Cancer Specialized Register, Clinical Trials.gov and American Society of Clinical Oncology. From 168 records screened, 15 full text articles were assessed for eligibility and only 7 studies met the inclusion criteria. Three of the studies included analyzed changes in Ki-67 expression, revealing weaker expression after treatment with acolbifene and raloxifene (P
ISSN:2218-676X
2219-6803
DOI:10.21037/tcr-19-1956